CROISSANCE (CROISSANCE) Fair Value & Analysis

IN · Market cap ₹78.1M

C CROISSANCE CROISSANCE · BSE

Price₹1.14

Fair Value₹0.3300

Upside-71.1%

Quality44/100

Watch CROISSANCE for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range ₹0.2300 – ₹0.3700

Fair value as of: Jul 5, 2026

From 9 valuation models · updated today

Share price −15.6% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹1.13 – ₹4.15 · fair‑value band ₹0.2300 – ₹0.3700 · the ₹1.14 price screens above the ₹0.3300 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CROISSANCE (CROISSANCE) currently trades at ₹1.14, while our model-based Fair Value estimate is ₹0.3300 — implying the stock looks roughly 71.1% overvalued today. We read business quality at 44/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, CROISSANCE generated revenue of ₹8.1M at a net margin of 6.3%. It earns a return on equity of 0.7%. Net debt stands at ₹8.8M. The stock trades on a trailing P/E of 114.0. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹0.2300 (bear case) to ₹0.3700 (bull case); at ₹1.14, the current price sits above that range. The share trades about 74% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹8.1M

Revenue growth (YoY) +92,233%

Net margin 6.3%

Return on equity 0.7%

Free cash flow −₹4.5M FY2026

P/E ratio 114.0

More key figures

Operating margin 8.3%

EPS (TTM) ₹0.0100

EPS growth (YoY) -99.1%

Net debt ₹8.8M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CROISSANCE reported revenue of ₹6.1M in FY2026 versus ₹2.0M in FY2022, a compound +32.1%/yr. Reported net income was ₹509K in FY2026, compounding −21.2%/yr from FY2022.

Revenue +32.1%/yr

FY22 ₹2.0M

FY23 ₹26.0M

FY24 ₹6.6M

FY25 ₹1.0M

FY26 ₹6.1M

Net income −21.2%/yr

FY22 ₹1.3M

FY23 ₹4.9M

FY24 ₹684K

FY25 ₹1.0K

FY26 ₹509K

Is CROISSANCE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

CROISSANCE · Fair Value
₹0.3300 −71%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/CROISSANCE" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">CROISSANCE · Fair Value</span><br><b style="font-size:20px">₹0.3300</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−71%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "CROISSANCE Fair Value". https://www.fairvalue-calculator.com/stock/CROISSANCE

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is CROISSANCE (CROISSANCE) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹0.3300 versus a price of ₹1.14 — about −71% (overvalued). Model-based estimate, not financial advice.

What is the fair value of CROISSANCE?

Our model-based fair value for CROISSANCE is ₹0.3300 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹1.14.

What is the quality score of CROISSANCE?

CROISSANCE has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of CROISSANCE (CROISSANCE)?

CROISSANCE reported trailing-twelve-month revenue of about ₹8.1M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of CROISSANCE?

The net profit margin of CROISSANCE is about 6.3%, meaning it keeps roughly 6.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.